|
1
|
Weller M, Felsberg J, Hartmann C, et al:
Molecular predictors of progression-free and overall survival in
patients with newly diagnosed glioblastoma: a prospective
translational study of the German Glioma Network. J Clin Oncol.
27:5743–50. 2009. View Article : Google Scholar
|
|
2
|
Arany Z, Foo SY, Ma Y, et al:
HIF-independent regulation of VEGF and angiogenesis by the
transcriptional coactivator PGC-1 alpha. Nature. 451:1008–1012.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng SQ, Huang RQ and Zhang YJ: Role of
matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial
growth factor C in lymph node metastasis of breast cancer [J].
Zhonghua Bing Li Xue Za Zhi. 39:240–244. 2010.PubMed/NCBI
|
|
4
|
Sulman EP and Aldape K: The use of global
profiling in biomarker development of gliomas. Brain Pathol.
21:88–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inamura T, Nishio S, Takeshita I, Fujiwara
S and Fukui M: Peritumoral brain edema in meningiomas influence of
vascular supply on its development. Neurosurgery. 31:179–185. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Piroth MD, Pinkawa M, Holy R, Stoffels G,
Demirel C, Attieh C, Kaiser HJ, Langen KJ and Eble MJ:
Integrated-boost IMRT or 3-D-CRT using PET-PET based auto-contoured
target volume delineation for glioblastoma multiforme - a
dosimetric comparison. Radiat Oncol. 4:572009.
|
|
8
|
Brandes AA, Tosoni A, Franceschi E, Reni
M, Gatta G and Vecht C: Glioblastoma in adults. Crit Rev Oncol
Hematol. 67:139–152. 2008. View Article : Google Scholar
|
|
9
|
Chan ES and Yeh MM: The use of
immunohistochemistry in liver tumors. Clin Liver Dis. 14:687–703.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sethi K, Sarkar S, Das S, Mohanty B and
Mandal M: Biomarkers for the diagnosis of thyroid cancer. J Exp
Ther Oncol. 8:341–352. 2010.PubMed/NCBI
|
|
11
|
Chen W and Silverman DH: Advances in
evaluation of primary brain tumors. Semin Nucl Med. 38:240–250.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Costello JF: DNA methylation in brain
development and gliomagenesis. Front Biosci. 8:s175–s184. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diamandis EP, Fritsche HA, Lilja H, Daniel
WC and Schwartz MK: Tumor Markers: Physiology, Pathobiology,
Technology, and Clinical Applications. AACC press; Washington DC:
pp. 172002
|
|
14
|
Puduvalli VK and Sawaga R:
Antiangiogenesis therapeutic stragegios and clinical implications
for brain tumors. J Neurooncol. 50:189–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Amãlinei C, Cãruntu ID, Giuscã SE and
Bãlan RA: Matrix metalloproteinases involvement in pathologic
conditions. Rom J Morphol Embryol. 51:215–228. 2010.
|
|
16
|
Savinov AY and Strongin AY: Matrix
metalloproteinases, T cell homing and beta-cell mass in type 1
diabetes. Vitam Horm. 80:541–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martin MD and Matrisian LM: The other side
of MMPs: protective roles in tumor progression. Cancer Metastasis
Rev. 26:717–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Langer A: A systematic review of PET and
PET/CT in oncology: a way to personalize cancer treatment in a
cost-effective manner? BMC Health Serv Res. 10:283–299. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen CQ, Liao WH and Chen CY: Correlation
between peritumoral edema on MRI, VEGF expression, MVD and
pathological grading in astrocytomas. Chin J Mod Med. 14:38–43.
2004.
|
|
20
|
Deng GX, Zhang H and Qian LX: Ordinal
logistic regression analysis of MRl and pathological grade in
astrocytoma. Chin Remed Clin. 5:680–682. 2005.
|
|
21
|
Anderson JC, Grammer JR, Wang W, Nabors
LB, Henkin J, Stewart JE Jr and Gladson CL: ABT-510, a modified
type 1 repeat peptide of thrombospondin, inhibits malignant glioma
growth in vivo by inhibiting angiogenesis. Cancer Biol Ther.
6:454–462. 2007. View Article : Google Scholar : PubMed/NCBI
|
